{"id":"https://openalex.org/W2052239068","doi":"https://doi.org/10.1016/j.bmcl.2013.03.015","title":"Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors","display_name":"Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors","publication_year":2013,"publication_date":"2013-03-14","ids":{"openalex":"https://openalex.org/W2052239068","doi":"https://doi.org/10.1016/j.bmcl.2013.03.015","mag":"2052239068","pmid":"https://pubmed.ncbi.nlm.nih.gov/23541670"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2013.03.015","doi":"https://doi.org/10.1016/j.bmcl.2013.03.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.03.015","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037870047","display_name":"Saul Jaime\u2010Figueroa","orcid":"https://orcid.org/0000-0002-2589-4974","observed_orcids":["https://orcid.org/0000-0002-2589-4974"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Saul Jaime-Figueroa","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, USA. saul.jaime@roche.com","Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, USA. saul.jaime@roche.com","institution_ids":[]},{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101879409","display_name":"Javier de Vicente","orcid":"https://orcid.org/0000-0003-2498-0843","observed_orcids":["https://orcid.org/0000-0003-2498-0843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier De Vicente","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066381646","display_name":"Johannes C. Hermann","orcid":"https://orcid.org/0000-0003-2686-3771","observed_orcids":["https://orcid.org/0000-0003-2686-3771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes Hermann","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113521805","display_name":"Alam Md. Jahangir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alam Jahangir","raw_affiliation_strings":["Roche Palo Alto, 3401 Hillview Ave, Palo Alto, CA 94304, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto, 3401 Hillview Ave, Palo Alto, CA 94304, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018930100","display_name":"Sue Jin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sue Jin","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088408344","display_name":"A. Kuglstatter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Kuglstatter","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","Roche Palo Alto, 3401 Hillview Ave, Palo Alto, CA 94304, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]},{"raw_affiliation_string":"Roche Palo Alto, 3401 Hillview Ave, Palo Alto, CA 94304, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066715069","display_name":"Stephen M. Lynch","orcid":"https://orcid.org/0000-0002-4402-5942","observed_orcids":["https://orcid.org/0000-0002-4402-5942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen M. Lynch","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109863404","display_name":"John G. Menke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Menke","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011096203","display_name":"Linghao Niu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linghao Niu","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023698650","display_name":"Vaishali Pavalbhai Patel","orcid":"https://orcid.org/0000-0003-2812-207X","observed_orcids":["https://orcid.org/0000-0003-2812-207X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vaishali Patel","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110166955","display_name":"A. Shao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ada Shao","raw_affiliation_strings":["Roche Palo Alto, 3401 Hillview Ave, Palo Alto, CA 94304, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto, 3401 Hillview Ave, Palo Alto, CA 94304, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068873272","display_name":"Michael Soth","orcid":"https://orcid.org/0000-0002-2649-5537","observed_orcids":["https://orcid.org/0000-0002-2649-5537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Soth","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103460640","display_name":"Minh Diem Vu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minh Diem Vu","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077523113","display_name":"Calvin Yee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Calvin Yee","raw_affiliation_strings":["Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110-1199, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5037870047"],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.2232,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.8721146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"23","issue":"9","first_page":"2522","last_page":"2526"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.4812000095844269,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.4812000095844269,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4027999937534332,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.02199999988079071,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak3-inhibitors","display_name":"JAK3 inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/jak3","display_name":"JAK3","score":0.8069999814033508},{"id":"https://openalex.org/keywords/phenyl-ethers","display_name":"phenyl ethers","score":0.699999988079071},{"id":"https://openalex.org/keywords/atp-competitive-kinase-inhibitors","display_name":"ATP-competitive kinase inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.6669999957084656},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6620000004768372},{"id":"https://openalex.org/keywords/crystallographic-analysis","display_name":"crystallographic analysis","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8784738183021545},{"id":"https://openalex.org/C2777765701","wikidata":"https://www.wikidata.org/wiki/Q424284","display_name":"Pyrazine","level":2,"score":0.8221176862716675},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.7745250463485718},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.7256336212158203},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6106020212173462},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5507595539093018},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.48690974712371826},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4635576009750366},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4499663710594177},{"id":"https://openalex.org/C2780407432","wikidata":"https://www.wikidata.org/wiki/Q103230","display_name":"Ether","level":2,"score":0.42416203022003174},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.32704776525497437},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28517574071884155},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15832704305648804},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09589886665344238},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010647","descriptor_name":"Phenyl Ethers","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010647","descriptor_name":"Phenyl Ethers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010647","descriptor_name":"Phenyl Ethers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020134","descriptor_name":"Catalytic Domain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D053616","descriptor_name":"Janus Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053616","descriptor_name":"Janus Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.bmcl.2013.03.015","doi":"https://doi.org/10.1016/j.bmcl.2013.03.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.03.015","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:23541670","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23541670","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:dora:psi_10357","doi":null,"is_oa":false,"landing_page_url":"https://www.dora.lib4ri.ch/psi/item/psi:10357","pdf_url":null,"source":{"id":"https://openalex.org/S4306402574","display_name":"DORA PSI (Paul Scherrer Institute)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2802229908","host_organization_name":"Paul Scherrer Institute","host_organization_lineage":["https://openalex.org/I2802229908"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Bioorganic and Medicinal Chemistry Letters","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1558319187","https://openalex.org/W1963518763","https://openalex.org/W1995629248","https://openalex.org/W2012982660","https://openalex.org/W2044086940","https://openalex.org/W2061785558","https://openalex.org/W2062650417","https://openalex.org/W2090058745","https://openalex.org/W2101217991","https://openalex.org/W2153414586","https://openalex.org/W2169436688","https://openalex.org/W4244757272"],"related_works":["https://openalex.org/W2049646455","https://openalex.org/W2919805078","https://openalex.org/W1968112651","https://openalex.org/W1978888576","https://openalex.org/W2039597468","https://openalex.org/W2016922576","https://openalex.org/W7212366019","https://openalex.org/W2782614633","https://openalex.org/W2132640211","https://openalex.org/W2044086940"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}